L Lashnews Medical aesthetics sourcing from China
News Sourcing Guide

【South Korea】Amorepacific Expands Into Medical Aesthetics With Strategic Investment in Higher Corporation

Editor’s Note

**Editor’s Note:** Amorepacific’s latest partnership signals a strategic move to integrate professional aesthetic treatments with everyday skincare, spanning skin boosters, cosmeceuticals, medical devices, and post-treatment care.

Partnership aims to bridge professional aesthetic treatments and daily skincare
Collaboration covers skin boosters, cosmeceuticals, medical devices and post-treatment care

South Korea’s beauty giant Amorepacific is accelerating its push into the fast-growing medical aesthetics market through a strategic investment in Higher Corporation, a skin aesthetic medical device company.

Amorepacific Holdings announced on July 27 that it had signed an investment agreement with Higher Corporation to strengthen cooperation in the beauty and medical aesthetics sectors.

The deal signals the company’s intention to expand beyond traditional cosmetics into medical devices, aesthetic treatments and integrated skincare solutions.

The partnership reflects a broader shift occurring across the global beauty industry. While beauty companies have traditionally focused on skincare, makeup and haircare products, consumer demand is increasingly expanding into areas such as skin boosters, aesthetic medical devices, post-procedure skincare and home beauty technologies.

As consumers seek comprehensive skin management solutions that combine cosmetics with professional treatments, beauty companies are moving deeper into the medical aesthetics ecosystem. Industry observers view Amorepacific’s investment as a strategic response to this trend.

Under the agreement, the two companies will combine Higher Corporation’s expertise in aesthetic medical devices and its global network of medical professionals with Amorepacific’s skin science capabilities and skincare technologies. The collaboration will include joint planning, research and development, distribution and marketing initiatives.

The companies plan to cooperate in the development and commercialization of skin boosters, cosmeceuticals, aesthetic medical devices and post-treatment skincare products. They will also explore collaboration in medical and clinic distribution channels.

Industry experts see the core value of the partnership in connecting professional aesthetic procedures with daily skincare routines.

The strategy aims to provide consumers with a continuous skincare experience, covering pre-treatment preparation, post-procedure recovery and long-term skin maintenance. By integrating cosmetic and medical solutions, the companies hope to create a new category of beauty-medical offerings.

One of the key advantages for Amorepacific is access to Higher Corporation’s professional medical network, which includes dermatology clinics, plastic surgery practices and aesthetic clinics. The partnership could help Amorepacific expand beyond its traditional consumer-focused retail channels into professional medical markets.

The deal may also enable the development of new products that combine cosmetics with medical technologies, including skin boosters, LED beauty devices and regenerative post-treatment skincare solutions.

For Higher Corporation, the partnership provides access to Amorepacific’s advanced skin science research infrastructure, global brand strength and international distribution capabilities. These resources could support the company’s expansion into broader consumer and international markets.

Amorepacific Holdings has signed a strategic investment agreement with Higher Corporation, a specialized aesthetic medical device company, to strengthen cooperation in the beauty and medical sectors. (Photo: Amorepacific)

Founded in 2021, Higher Corporation develops aesthetic medical devices and operates through a research model built around medical professionals and global distribution networks. Its flagship product, HILO WAVE®, is a Dual-HA collagen booster designed for skin regeneration and remodeling. The company currently operates in markets including South Korea, Japan, Indonesia and Vietnam.

Industry observers believe the investment represents more than a simple financial transaction. Instead, it signals Amorepacific’s broader ambition to evolve from a cosmetics company into a comprehensive beauty and medical aesthetics player.

As the boundaries between beauty, dermatology and medical technology continue to blur, the partnership could position Amorepacific to capture new growth opportunities in the global beauty-medical market.

Full article: View original |
⏰ Published on: July 28, 2026